GPDMP's email address is provided, along with website addresses for general information, queries, and data uploads. Contact information is provided for the Program Coordinator and the Administrative Officer. Statistics for 2017 cover the Guam population (165,374), DEA registered prescribers (368), and DEA registered dispensers (25). GPDMP available reports are listed. Funding sources for the GPDMP in 2018 are reported to be the controlled substance registration fee and the Harold Rogers grant. Staff numbers are reported for the following job categories: operational (1), technical (1), analytical (1), and "other" (0). Key dates for the GPDMP are enabling legislation (1972.1998, and 2012); becoming operational (2013); on-line access (2013); and electronic reporting (2013). Access information is provided for relevant statutes and rules for the GPDMP. The GPDMP monitors prescription drugs under schedules II, III, IV, and V, and has the authority to monitor other substances. Other GPDMP capabilities and policies are also listed. Dispensers of prescription drugs are required to enroll in the GPDMP, and prescribers are required to use the GPDMP. Law enforcement requirements for access to GPDMP are an active drug-related investigation and probable cause, as well as a written request. Requirements are shown for the following technological capabilities: ASAP versions accepted; data transmission method allowed; required data transmitters; data collection, storage, generation, and access; and patient matching. Requestor types and reports they are authorized to produce are indicated, along with those that are currently producing various types of reports.
Prescription Drug Monitoring Program: Guam Territory Profile
NCJ Number
252996
Date Published
August 2018
Length
8 pages
Annotation
Information and data are presented for the Guam Territory's Prescription Drug Monitoring Program (GPDMP), which is administered by Guam's Department of Public Health and Social Services.
Abstract